BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12769640)

  • 1. Erythropoietin: cytoprotection in vascular and neuronal cells.
    Chong ZZ; Kang JQ; Maiese K
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Jun; 3(2):141-54. PubMed ID: 12769640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and plasticity: role of erythropoietin in vascular systems.
    Chong ZZ; Kang JQ; Maiese K
    J Hematother Stem Cell Res; 2002 Dec; 11(6):863-71. PubMed ID: 12590701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
    Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
    Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades.
    Chong ZZ; Kang JQ; Maiese K
    J Cereb Blood Flow Metab; 2002 May; 22(5):503-14. PubMed ID: 11973422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
    Chong ZZ; Lin SH; Kang JQ; Maiese K
    J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting erythropoietin for chronic neurodegenerative diseases.
    Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K
    Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.
    Li F; Chong ZZ; Maiese K
    Neurosignals; 2004; 13(6):265-89. PubMed ID: 15627815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases.
    Chong ZZ; Kang JQ; Maiese K
    Circulation; 2002 Dec; 106(23):2973-9. PubMed ID: 12460881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin in the brain: can the promise to protect be fulfilled?
    Maiese K; Li F; Chong ZZ
    Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways.
    Chong ZZ; Kang JQ; Maiese K
    Br J Pharmacol; 2003 Mar; 138(6):1107-18. PubMed ID: 12684267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
    Arcasoy MO; Jiang X
    Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of erythropoietin against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involving the EPOR-Erk1/2-Nrf2/Bach1 signal pathway.
    Zhang DX; Zhang LM; Zhao XC; Sun W
    Biomed Pharmacother; 2017 Mar; 87():332-341. PubMed ID: 28064106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin: physiology and pharmacology update.
    Fisher JW
    Exp Biol Med (Maywood); 2003 Jan; 228(1):1-14. PubMed ID: 12524467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
    Ruscher K; Freyer D; Karsch M; Isaev N; Megow D; Sawitzki B; Priller J; Dirnagl U; Meisel A
    J Neurosci; 2002 Dec; 22(23):10291-301. PubMed ID: 12451129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin as an antiapoptotic, tissue-protective cytokine.
    Ghezzi P; Brines M
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S37-44. PubMed ID: 15243580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
    Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
    FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
    Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.
    Digicaylioglu M; Lipton SA
    Nature; 2001 Aug; 412(6847):641-7. PubMed ID: 11493922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.